Vree T B, van Dongen R T, Koopman-Kimenai P M
Institute for Anaesthesiology, Academic Hospital St Radboud, Nijmegen, The Netherlands.
Int J Clin Pract. 2000 Jul-Aug;54(6):395-8.
Eighty per cent of codeine is conjugated with glucuronic acid to codeine-6-glucuronide. Only 5% of the dose is O-demethylated to morphine, which in turn is immediately glucuronidated at the 3- and 6-position and excreted renally. Based on the structural requirement of the opiate molecule for interaction with the mu-receptor to result in analgesia, codeine-6-glucuronide in analogy to morphine-6-glucuronide must be the active constituent of codeine. Poor metabolisers of codeine, those who lack the CYP450 2D6 isoenzyme for the O-demethylation to morphine, experience analgesia from codeine-6-glucuronide. Analgesia of codeine does not depend on the formation of morphine and the metaboliser phenotype.
80%的可待因与葡萄糖醛酸结合形成可待因-6-葡萄糖醛酸酯。只有5%的剂量会O-去甲基化生成吗啡,而吗啡又会立即在3位和6位进行葡萄糖醛酸化,并通过肾脏排泄。基于阿片类分子与μ受体相互作用以产生镇痛作用的结构要求,与吗啡-6-葡萄糖醛酸酯类似,可待因-6-葡萄糖醛酸酯必定是可待因的活性成分。可待因代谢能力差的人,即那些缺乏用于将可待因O-去甲基化生成吗啡的CYP450 2D6同工酶的人,会从可待因-6-葡萄糖醛酸酯中获得镇痛效果。可待因的镇痛作用并不取决于吗啡的形成以及代谢者的表型。